Basic Info
Model NO.: 188627-80-7
Trademark: Simeiquan
Specification: 98% min
Origin: China
HS Code: 2901100000Product DescriptionEptifibatide
Product Name:Eptifibatide
CAS:188627-80-7
MF:C35H49N11O9S2
MW:831.96
Usage:A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
Appearance | White crystalline powder |
Package | 1g/aluminium foil bag or as required |
Usage | can be used as weightloss |
Minimum order quantity | 1g |
passment | Professional team special for package and shipment and staring |
| on tracking code 24hours for customs pass guaranteed |
Shipping | By express courier |
Shipping leading time | Within 24 hours after receiving the payment |
Payment options | Western Union, MoneyGram, T/T,Bank transfer |
shipping | 1)Express delivery with DHL,EMS,FedEx,HKEMS,TNT,UPS |
| (Express delivery within 24 hours after payment) |
| 2)By sea (large quantity ,it will take 30-45days) |
Price | Negotiated |
Supply ability | 50g/Month |
Loss weight Product list |
Steroid For Weight Loss |
| Turinabol CAS NO.: 855-19-6 |
Boldenone undecylenate CAS:-34-9 | Arimidex Powder CAS:120511-73-1 |
Drostanolone Enanthate | Drostanolone Propionate CAS: 521-12-0 |
Clomiphene Citrate CAS NO: 50-41-9 | Clostebol Acetate CAS:855-19-6 |
CAS: 76-43-7 |
|
Testosterone Enanthate CAS No.: 315-37-7 | Proviron CAS NO.: 1424-00-6 |
Nandrolone Decanoate CAS NO.: 360-70-3 | Trenbolone Acetate CAS:10161-34-9 |
Anavar CAS:53-39-4 | Nandrolone Decanoate CAS:360-70-3 |
Weight Loss |
Rimonabant CAS:168273-06-1 | L (-) -Carnitine CAS: 541-15-1 |
| Eptifibatide CAS:188627-80-7 |
1,3-Dimethylpentylamine CAS:105-41-9 |
|
Brief introduction:
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Indications
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (I.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.
The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.
Contraindications and precautions
Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.
Renal insufficiency : Eptifibatide undergoes renal elimination. In such patients with renal insufficiency where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, Abciximab (trade name: Reopro) is an alternative medication.
Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.
Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.
Allergy to eptifibatide and/or other ingredients.
Severe, uncontrolled hypertension.
Pregnancy : No experience exists. Pregnant patients should be treated only when clearly needed.
Lactation : No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.
Geriatric patients : No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.
Pediatric patients : Eptifibatide is not indicated in patients below 18 years of age, because no experience exists
Packaging & Delivery
We have professional team for package and shipment. Special way to ship 100 grams to 100kg powders at one time to your country. Fast and discreet shipment could be arranged for customs pass Guaranteed.
Our advantages
1,Years old factory:Simeiquan Biotechnology Co., Ltd. is a professional raw powder factory in China for over 10 years, all powders are factory directly supplying.
2,Export forceful:Our products have exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Australia, Japan, Korea and many other countries, over 100kgs each month.
3,High passment:Professional team special for package and shipment and staring on tracking code 24hours for customs pass guaranteed. 100% pass to UK, Norway, Poland, Spain, USA, Canada, Brazil; 98% pass to Germany, Russia, Australia, New Zealand.
4,Fast delivery :Most of powders are in stock, Chargeable samples are available, Could be shipped out within 24hours.High quality, good price, fast and safety delivery. Shipment by DHL, TNT, FedEx, HKEMS, UPS, etc.
5,Flexible price:A discount would be given when you make a large order.
6,Good after-sale service:
Warm aftersale service for you 24/7. Any of your question would be solved for the first as soon as possible
Offer semi-finished oral liquid( (Dianabol) Clomifene citrate (Clomid) )
Product Tags:Eptifibatide,Rimonabant,188627-80-7,weight loss,,3-Dimethylpentylamine